Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

BACKGROUND: The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections. Clinicians often continue vancomycin started empirically even when meth...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schweizer, Marin L, Furuno, Jon P, Harris, Anthony D, Johnson, J Kristie, Shardell, Michelle D, McGregor, Jessina C, Thom, Kerri A, Cosgrove, Sara E, Sakoulas, George, Perencevich, Eli N
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206863/
https://ncbi.nlm.nih.gov/pubmed/22011388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-11-279
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars